Wendall Wierenga, Director at ONYX PHARMACEUTICALS INC (ONXX), sold 250 shares at $37.67 ($9K) on 2011-05-02, disclosed to the SEC on 2011-05-02.
Scheduled sale ($9k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CYTK | SELL | 2024-11-26 | $37K | — | Filing → |
| CYTK | SELL | 2024-10-31 | $233K | — | Filing → |
| CYTK | SELL | 2023-12-27 | $368K | — | Filing → |